Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stuart Rich, MD
Tenax Therapeutics, Inc.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford Healthcare
Stanford, California, United States
- Northwestern Memorial Hospital
Chicago, Illinois, United States
- University of Minnesota Medical Center
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Upmc Presbyterian Hospital
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Uw Health University Hospital
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Apr 2019
- Primary completion
- 25 Apr 2023
- Completion
- 25 Apr 2023
- Last update posted
- 22 Apr 2026
- Registered enrollment
- 35
- Registry id
- NCT03624010
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.